Nissay Asset Management Corp Ionis Pharmaceuticals Inc Transaction History

Nissay Asset Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$34.54 - $47.25 $490,606 - $671,139	-14,204 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$42.51 - $63.78 $11,690 - $17,539	-275 Reduced 1.9%	14,204 $639,000
Q4 2020 Feb 08, 2021	BUY	$45.3 - $60.27 $35,560 - $47,311	785 Added 5.73%	14,479 $819,000
Q3 2020 Oct 20, 2020	BUY	$47.45 - $62.95 $11,815 - $15,674	249 Added 1.85%	13,694 $650,000
Q2 2020 Jul 27, 2020	BUY	$46.85 - $61.05 $67,229 - $87,606	1,435 Added 11.95%	13,445 $793,000
Q1 2020 May 05, 2020	BUY	$41.6 - $63.4 $18,512 - $28,213	445 Added 3.85%	12,010 $568,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $28,378 - $34,397	527 Added 4.77%	11,565 $699,000
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $39,747 - $48,556	673 Added 6.49%	11,038 $661,000
Q2 2019 Aug 07, 2019	BUY	$62.09 - $86.14 $643,562 - $892,841	10,365 New	10,365 $666,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Nissay Asset Management Corp with notifications on news.